Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jan 16, 2024; 12(2): 276-284
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.276
Table 1 Clinicopathological characteristics of patients enrolled in this cohort
Variables
Hepatectomy (n = 234)
Age, yr72 (33-93)
Sex (male/ female) (%)177/57 (76/24)
Disease (%)
    Hepatocellular carcinoma198 (84)
    Intrahepatic cholangiocarcinoma11 (5)
    Perihilar cholangiocarcinoma25 (11)
Surgical procedures
    Major hepatectomy59 (25)
    Minor hepatectomy175 (75)
    Laparotomy40
    Laparoscopic135
Operation time (min)410 (92-762)
Blood loss (mL)150 (0-5330)
VTE13 (5.6)
    DVT12
    PE2
Table 2 Comparison of clinicopathological factors with and without venous thromboembolism in the patients with hepatectomy (n = 192)
Variables
VTE (+) (n = 12)
VTE (-) (n = 180)
P value
Age, yr (range) (median)73 (59-84)72 (33-91)0.4635
Sex
    Male/female9 (75)/3 (25)135 (75)/45 (25)0.65
BMI (kg/m2) (median)23.4 (17.7-28.3)22.7 (13.1-38.9)0.7864
Disease
    HCC8148
    IHCC011
    PHCC421
Major/minor hepatectomy (%)6 (50)/6(50)45 (25)/135(75)0.0576
Laparoscopy (%)4 (33)109 (61)0.0635
Smoking (%)8 (67)109 (61)0.6744
Hypertension (%)9 (75)95 (53)0.1347
Diabetes mellitus (%)5 (42)64 (36)0.6692
Cardiovascular disease (%)1 (8)20 (11)0.7653
Anticoagulation (%)2 (17)19 (11)0.5114
History of VTE00-
DVT/PE11/20/0
Operation time (min) (median)529 (250-611)403 (92-762)0.0274
Blood loss (mL) (median)530 (10-2515)138 (10-5330)0.0067
Postoperative complication (≥ CDIIIb)1 (8)4 (2)0.1984
Ddimer (μg/mL) (median)
    POD1 (range)10.4 (5-21.7)6 (1.1-48.5)0.005
    POD3 (range)16.7 (4.7-54.6)7.3 (1.1-75)0.0029
    POD5 (range)29.5 (12.9-65)13.3 (2.7-167.3)0.0163
    POD7 (range)26.1 (15.1-75.8)15.5 (2.2-138.9)0.0029
Table 3 Detailed list of the patients with venous thromboembolism (n = 12)
No.
Disease
Extent of resection
Date of diagnosis
D-dimer (time of diagnosis)
Method of diagnosis
Diagnosis
Treatment
1HCC + GCPartial (S7)POD 720.6USDVTAnticoagulant
2HCCSegmental (S5 + 8)POD 1532.3USDVTAnticoagulant
3HCCSegmental (S6 + 7)POD 755.6USDVTAnticoagulant
4HCCSegmental (S4) + partial (S8)POD 330.2USDVTObservation
5HCCRight lobectomy + partial (S2)POD 723.1USDVTObservation
6PHCCLeft hemihepatectomyPOD 775.8CECTPEAnticoagulant
7PHCCLeft hemihepatectomyPOD 657.8CECTPE/DVTAnticoagulant
8HCCSegmental (S5 + 8)POD 725.5USDVTObservation
9PHCCLeft hemihepatectomyPOD 2117.4USDVTObservation
10PHCCLeft hemihepatectomyPOD 715.1CECTPEAnticoagulant
11HCCSegmental (S6 + 7)POD 1137.3USDVTAnticoagulant
12HCCRight hemihepatectomyPOD 743.6USDVTObservation
Table 4 Logistic regression analyses of factors associated with venous thromboembolism among patients undergoing hepatectomy
VariablesUnivariate analysis
Multivariate analysis
OR
95%CI
P value
OR
95%CI
P value
Sex (female)1.00.26-3.861.0
Age ≥ 70 yr1.20.35-4.190.7585
Major hepatectomy30.10-1.090.0682
Minimally invasivehepatectomy3.070.89-10.60.0755
BMI ≥ 25 kg/m21.170.34-4.040.8078
HT2.680.70-10.20.1484
DM1.290.39-4.250.6700
Cardiovascular disease0.720.09-5.930.7662
Smoking1.30.38-4.490.6751
Anticoagulation1.70.25-8.310.5157
Ope time ≥ 462 (min)5.31.39-20.30.01473.370.80-14.20.0978
Blood loss ≥ 275 (mL)102.12-47.10.00365.321.05-27.00.0435
Blood transfusion4.48e-70.9902
DD (POD 5) ≥ 21 (μg/mL)14.83.11-70.1< 0.000110.12.04-50.10.0046
Complication (≥ CDIIIb)4.00.41-38.80.2322